Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
MRM Quote, Financials, Valuation and Earnings
Last price:
$1.43
Seasonality move
:
-6.94%
Day range:
$1.34 - $1.43
52-week range:
$0.34 - $8.39
Dividend yield:
0%
P/E ratio:
7.06x
P/S ratio:
0.15x
P/B ratio:
1.85x
Volume:
41K
Avg. volume:
29.8K
1-year change:
-65.44%
Market cap:
$11M
Revenue:
$54.9M
EPS (TTM):
-$0.12
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
-- | -- | -- | -- | $4.98 |
|
HMC
Honda Motor
|
$36.2B | -- | -0.29% | -- | $36.76 |
|
LGCB
Linkage Global
|
-- | -- | -- | -- | -- |
|
NPSKY
NSK
|
-- | -- | -- | -- | -- |
|
TKLF
Tokyo Lifestyle
|
-- | -- | -- | -- | -- |
|
TRYIY
Toray Industries
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
$1.39 | $4.98 | $11M | 7.06x | $0.00 | 0% | 0.15x |
|
HMC
Honda Motor
|
$30.55 | $36.76 | $41.7B | 8.74x | $0.71 | 4.53% | 0.33x |
|
LGCB
Linkage Global
|
$2.47 | -- | $18.7M | -- | $0.00 | 0% | 0.76x |
|
NPSKY
NSK
|
$9.11 | -- | $2.2B | 31.84x | $0.23 | 5.08% | 0.42x |
|
TKLF
Tokyo Lifestyle
|
$4.02 | -- | $17M | 2.55x | $0.00 | 0% | 0.09x |
|
TRYIY
Toray Industries
|
$13.41 | -- | $10.3B | 20.55x | $0.12 | 1.82% | 0.63x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
129.27% | 7.095 | 51.51% | 0.23x |
|
HMC
Honda Motor
|
26.4% | -0.964 | 71.52% | 1.00x |
|
LGCB
Linkage Global
|
18.89% | -1.528 | 2.68% | 0.70x |
|
NPSKY
NSK
|
-- | 0.226 | -- | 1.44x |
|
TKLF
Tokyo Lifestyle
|
61.76% | 0.162 | 428.69% | 1.04x |
|
TRYIY
Toray Industries
|
31.87% | 1.189 | 47.02% | 1.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MRM
MEDIROM Healthcare Technologies
|
-- | -- | -6.44% | -- | -- | -- |
|
HMC
Honda Motor
|
$7.5B | $482.4M | 5.61% | 6.34% | 2.03% | -$990.6M |
|
LGCB
Linkage Global
|
-- | -- | -29.38% | -42.09% | -- | -- |
|
NPSKY
NSK
|
$271.2M | $25.2M | 1.54% | 1.57% | 3.42% | -$21.3M |
|
TKLF
Tokyo Lifestyle
|
-- | -- | -0.56% | -1.49% | -- | -- |
|
TRYIY
Toray Industries
|
$801.7M | $159.3M | 2.87% | 4.2% | 5.27% | $262.1M |
MEDIROM Healthcare Technologies vs. Competitors
-
Which has Higher Returns MRM or HMC?
Honda Motor has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.57%. MEDIROM Healthcare Technologies's return on equity of -- beat Honda Motor's return on equity of 6.34%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M HMCHonda Motor21.23% $0.18 $113.9B -
What do Analysts Say About MRM or HMC?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 258.59%. On the other hand Honda Motor has an analysts' consensus of $36.76 which suggests that it could grow by 20.32%. Given that MEDIROM Healthcare Technologies has higher upside potential than Honda Motor, analysts believe MEDIROM Healthcare Technologies is more attractive than Honda Motor.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 HMCHonda Motor2 1 0 -
Is MRM or HMC More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Honda Motor has a beta of 0.483, suggesting its less volatile than the S&P 500 by 51.657%.
-
Which is a Better Dividend Stock MRM or HMC?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Honda Motor offers a yield of 4.53% to investors and pays a quarterly dividend of $0.71 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Honda Motor pays out 41.61% of its earnings as a dividend. Honda Motor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MRM or HMC?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Honda Motor quarterly revenues of $35.2B. MEDIROM Healthcare Technologies's net income of -- is lower than Honda Motor's net income of $200.5M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 7.06x while Honda Motor's PE ratio is 8.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.15x versus 0.33x for Honda Motor. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.15x 7.06x -- -- HMCHonda Motor0.33x 8.74x $35.2B $200.5M
-
Which has Higher Returns MRM or LGCB?
Linkage Global has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Linkage Global's return on equity of -42.09%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M LGCBLinkage Global-- -- $8.3M -
What do Analysts Say About MRM or LGCB?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 258.59%. On the other hand Linkage Global has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Linkage Global, analysts believe MEDIROM Healthcare Technologies is more attractive than Linkage Global.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 LGCBLinkage Global0 0 0 -
Is MRM or LGCB More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Linkage Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MRM or LGCB?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Linkage Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Linkage Global pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or LGCB?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Linkage Global quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Linkage Global's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 7.06x while Linkage Global's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.15x versus 0.76x for Linkage Global. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.15x 7.06x -- -- LGCBLinkage Global0.76x -- -- --
-
Which has Higher Returns MRM or NPSKY?
NSK has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 0.99%. MEDIROM Healthcare Technologies's return on equity of -- beat NSK's return on equity of 1.57%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M NPSKYNSK20.76% $0.05 $4.5B -
What do Analysts Say About MRM or NPSKY?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 258.59%. On the other hand NSK has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than NSK, analysts believe MEDIROM Healthcare Technologies is more attractive than NSK.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 NPSKYNSK0 0 0 -
Is MRM or NPSKY More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NSK has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.676%.
-
Which is a Better Dividend Stock MRM or NPSKY?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NSK offers a yield of 5.08% to investors and pays a quarterly dividend of $0.23 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. NSK pays out 146.95% of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or NPSKY?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than NSK quarterly revenues of $1.3B. MEDIROM Healthcare Technologies's net income of -- is lower than NSK's net income of $12.9M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 7.06x while NSK's PE ratio is 31.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.15x versus 0.42x for NSK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.15x 7.06x -- -- NPSKYNSK0.42x 31.84x $1.3B $12.9M
-
Which has Higher Returns MRM or TKLF?
Tokyo Lifestyle has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of --. MEDIROM Healthcare Technologies's return on equity of -- beat Tokyo Lifestyle's return on equity of -1.49%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M TKLFTokyo Lifestyle-- -- $98.1M -
What do Analysts Say About MRM or TKLF?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 258.59%. On the other hand Tokyo Lifestyle has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Tokyo Lifestyle, analysts believe MEDIROM Healthcare Technologies is more attractive than Tokyo Lifestyle.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 TKLFTokyo Lifestyle0 0 0 -
Is MRM or TKLF More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tokyo Lifestyle has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MRM or TKLF?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tokyo Lifestyle offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Tokyo Lifestyle pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRM or TKLF?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Tokyo Lifestyle quarterly revenues of --. MEDIROM Healthcare Technologies's net income of -- is lower than Tokyo Lifestyle's net income of --. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 7.06x while Tokyo Lifestyle's PE ratio is 2.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.15x versus 0.09x for Tokyo Lifestyle. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.15x 7.06x -- -- TKLFTokyo Lifestyle0.09x 2.55x -- --
-
Which has Higher Returns MRM or TRYIY?
Toray Industries has a net margin of -- compared to MEDIROM Healthcare Technologies's net margin of 3.12%. MEDIROM Healthcare Technologies's return on equity of -- beat Toray Industries's return on equity of 4.2%.
Company Gross Margin Earnings Per Share Invested Capital MRMMEDIROM Healthcare Technologies-- -- $7.7M TRYIYToray Industries19.42% $0.16 $17.5B -
What do Analysts Say About MRM or TRYIY?
MEDIROM Healthcare Technologies has a consensus price target of $4.98, signalling upside risk potential of 258.59%. On the other hand Toray Industries has an analysts' consensus of -- which suggests that it could fall by --. Given that MEDIROM Healthcare Technologies has higher upside potential than Toray Industries, analysts believe MEDIROM Healthcare Technologies is more attractive than Toray Industries.
Company Buy Ratings Hold Ratings Sell Ratings MRMMEDIROM Healthcare Technologies1 0 0 TRYIYToray Industries0 0 0 -
Is MRM or TRYIY More Risky?
MEDIROM Healthcare Technologies has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Toray Industries has a beta of 0.555, suggesting its less volatile than the S&P 500 by 44.504%.
-
Which is a Better Dividend Stock MRM or TRYIY?
MEDIROM Healthcare Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Toray Industries offers a yield of 1.82% to investors and pays a quarterly dividend of $0.12 per share. MEDIROM Healthcare Technologies pays -- of its earnings as a dividend. Toray Industries pays out 37.01% of its earnings as a dividend. Toray Industries's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MRM or TRYIY?
MEDIROM Healthcare Technologies quarterly revenues are --, which are smaller than Toray Industries quarterly revenues of $4.1B. MEDIROM Healthcare Technologies's net income of -- is lower than Toray Industries's net income of $128.8M. Notably, MEDIROM Healthcare Technologies's price-to-earnings ratio is 7.06x while Toray Industries's PE ratio is 20.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MEDIROM Healthcare Technologies is 0.15x versus 0.63x for Toray Industries. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRMMEDIROM Healthcare Technologies0.15x 7.06x -- -- TRYIYToray Industries0.63x 20.55x $4.1B $128.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
